Amedisys (STU:ADY) Additional Paid-In Capital : €731 Mil(As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Amedisys Additional Paid-In Capital?

Amedisys's quarterly additional paid-in capital declined from Sep. 2023 (€728 Mil) to Dec. 2023 (€722 Mil) but then increased from Dec. 2023 (€722 Mil) to Mar. 2024 (€731 Mil).

Amedisys's annual additional paid-in capital increased from Dec. 2021 (€644 Mil) to Dec. 2022 (€713 Mil) and increased from Dec. 2022 (€713 Mil) to Dec. 2023 (€722 Mil).

Amedisys Additional Paid-In Capital Historical Data

The historical data trend for Amedisys's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys Additional Paid-In Capital Chart

Amedisys Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

580.73

573.99

644.38

712.78

721.84

Amedisys Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															708.60	709.59	727.94	721.84	731.46

Amedisys Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Amedisys Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Amedisys's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Amedisys (STU:ADY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (STU:ADY) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

AMED:USA ADY:Germany

Address

3854 American Way, Suite A, Baton Rouge, LA, USA, 70816

Website

https://www.amedisys.com

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Amedisys (STU:ADY) Headlines

No Headlines